Last reviewed · How we verify
NCT06843421: K-MASLD
Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
trial in Metabolic Dysfunction-Associated Steatotic Liver Disease in 6,000 participants. Not yet recruiting.
1 May 2025
Quick facts
| Lead sponsor | Korea University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 6,000 |
| Start date | 1 March 2025 |
| Primary completion | 1 May 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 5 locations across South Korea |
Conditions studied
- Metabolic Dysfunction-Associated Steatotic Liver Disease — all drugs for Metabolic Dysfunction-Associated Steatotic Liver Disease →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Korea University
Who can join
19 and older, any sex, with Metabolic Dysfunction-Associated Steatotic Liver Disease or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to establish a multi-center registry to better understand Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using health screening data from Korean hospitals. MASLD is a liver condition where excess fat builds up in the liver and is closely linked to metabolic health problems like high blood pressure, diabetes, and obesity. The main questions this study aims to answer are: * What are the characteristics of people with MASLD? * How is MASLD related to other health conditions, especially heart and blood vessel diseases? * What factors might help identify MASLD early? Researchers will compare two groups of people: * People who have MASLD * People who don't have MASLD (control group) This study will look at health screening records from 2020 to 2023 from six Korean hospitals. The research team will collect and analyze: * Basic health information (age, gender, weight, height, waist size) * Lifestyle habits (drinking, smoking, exercise, eating habits) * Medical conditions (high blood pressure, diabetes, high cholesterol) * Results from medical tests including: Liver ultrasound and Fibroscan results Heart CT scans Blood vessel ultrasound Blood test results Other health screening results Participants in this study will not need to do anything new. The researchers will only look at information that was already collected during regular health screenings. All personal information will be protected and kept private. This research could help doctors: * Better understand who is at risk for MASLD * Find MASLD earlier * Develop better ways to prevent and treat MASLD * Understand how MASLD is connected to other health problems The study will take place over 3 years and includes adults age 19 and older who had health screenings at participating Korean hospitals. People who drink large amounts of alcohol or have other liver diseases will not be included in the study. By learning more about MASLD through this registry study, researchers hope to improve healthcare for people with or at risk for this liver condition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06843421
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Dysfunction-Associated Steatotic Liver Disease
Currently open trials in the same condition.
- NCT07450144 — A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease · NA · recruiting
- NCT07381257 — Efficacy and Safety of Rifaximin-α in Treating MASLD · EARLY_PHASE1 · recruiting
- NCT07192159 — Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD · NA · recruiting
- NCT07437157 — The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register · recruiting
- NCT07093346 — The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patient · NA · recruiting
Other Korea University trials
Trials by the same sponsor.
- NCT07328438 — Diagnosis Disclosure Support for Caregivers of Children With Autism · NA · not yet recruiting
- NCT07175701 — Ultra-processed Food-reducing Intervention and Continuous Glucose Monitoring · NA · recruiting
- NCT07485387 — Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort · recruiting
- NCT06523660 — Improving Executive Function in Korean Children With Autism · NA · active not recruiting
- NCT07342387 — Development of Microfluidic Patch-type Sweat Sensor · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06843421 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Korea University
- Last refreshed: 27 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06843421.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing